LONDON – Global law firm Dechert LLP advised Magyar Telecom B.V. (“Matel BV”) on the sale of its holding in the Invitel Group toto the China CEE Investment Co-operation Fund (whose investment adviser is CEE Equity Partners). The Invitel group is a leading Hungarian infrastructure-based telco and IT service provider. The Proposed Sale values the Invitel Group at an enterprise value of €202 million, and is subject to shareholder and Hungarian competition authority approval.

Shoosmiths has advised on the sale of Shetland based seafood producer, SI Seafarms Limited.

Rope grown mussel producer and supplier SI Seafarms has been bought by Blueshell Mussels Limited. The take over saw Blueshell Mussels Limited make an offer to all 78 shareholders of SI Seafarms Limited to purchase the entire share capital of company.

Based in Shetland, Blueshell Mussels is the UK's leading rope-grown mussel producer and operates the largest rope-grown mussel farm in the UK.

Herbert Smith Freehills has advised MESC Investments PSC and its shareholders including Dubai Islamic Bank on the sale of MESC Investments' indirect 52% equity stake in Jordan Dubai Islamic Bank, an Islamic financial institution listed on the Amman Stock Exchange.

Dubai Islamic Bank, the largest Islamic Bank in the United Arab Emirates, held an indirect 20.8% stake in Jordan Dubai Islamic Bank through its 40% shareholding in MESC Investments. The stake was purchased by a consortium comprising of Bank Al Etihad and Etihad Islamic Investment Company.

DLA Piper has, in respect to Swedish law, advised shareholders in Dhruva Interactive (P) Ltd on the divestment of 90.5 percent of the shares in the company to Starbreeze AB (publ) for a total purchase price amounting to USD 8.5 million of which USD 7 million will be paid in cash, and USD 1.5 million in the form of newly issued shares in Starbreeze AB (publ).

Shearman & Sterling is advising Hong Kong-listed Golden Meditech, a leading integrated healthcare company engaged in the development, manufacture, sales and distribution of blood-related medical devices and hospital management in China, on the sale of its stake in China Cord Blood for US$830 million. The transaction is expected to be completed by the first quarter of 2017.
 
Listed on the New York Stock Exchange, China Cord Blood is a leading provider of cord blood processing and storage services and is also the largest cord blood banking operator in China.

Osborne Clarke has advised Actavis UK Limited and Actavis Ireland Limited on its £603m divestment by Teva Pharmaceutical Industries Ltd (“Teva”) to Intas Pharmaceuticals Ltd (“Intas”).

The transaction is part of the European Commission’s anti-trust divestiture requirements arising from global pharmaceutical company Teva’s acquisition of Allergan’s generics business, which closed in August 2016.

Stephenson Harwood has advised the shareholders of Angela Swift Holdings Limited (ASHL) on the sale of luxury care homes operator Silk Healthcare to Methodist Homes.

Silk Healthcare operates four care homes, with a fifth in development. Methodist Homes will acquire and operate all five as part of the sale.

The deal was led by partner Karima Hudson, with support from partner Maryanna Sharrock (tax), senior associates Stewart Scott (real estate) and Oliver Jefferies (finance) and associate Michelle Gomes (corporate).

Davis Polk is advising Intime Retail (Group) Company Limited (“Intime”) on its HK$19.79 billion (approximately US$2.55 billion) proposed privatization by Alibaba Investment Limited and Intime International Holdings Limited as the joint offerors by way of a scheme of arrangement. The scheme is subject to, among other things, Cayman court sanction and independent shareholders’ approval of Intime.

Pinsent Masons has advised Teva Pharmaceuticals Industries Ltd. on its agreement to sell the assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd).

Baloîse (SIX: BALN) is to acquire a majority stake in publicly listed real-estate company Pax Anlage AG (SIX: PAXN). By entering into agreements with majority shareholders Pax Holding (Genossenschaft), Pax, Schweizerische Lebensversicherungs-Gesellschaft AG and Nürnberger Lebensversicherung AG, Baloîse Life Ltd will acquire around 70 per cent of the share capital and voting rights. Today, Baloîse published the pre-announcement of a public takeover offer for the remaining approx.